KEEPING AN OPEN MIND ON LONG-TERM USE OF PROTON PUMP INHIBITORS
Abstract
Since the release of omeprazole, the first proton pump inhibitor (PPI), in 1988 in Europe and, two years later, in the Unit-ed States, six other PPIs have become available such as pantoprazole, esomepra-zole, lansoprazole, dexlansoprazole, and rabeprazole. The discovery of omeprazole is the story of a huge therapeutic success, the result of over 20 years of hard work and meticulous research made by an extraordi-nary team of more than 150 researchers, who discovered and tested over 800 com-pounds, surmounting unimaginable obsta-cles.
References
2. Targownik L, Luo Y, Goertzen A, et al. Comparing bone structure and bone metabolism between long-term proton pump inhibitor users and non-users. Gastroenterology 2015; 148: S-153.
3. Othman F, Crooks CJ, Card TR. Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study. BMJ 2016; 355: i5813.
4. Shah NH, LePendu P, Bauer-Mehren A, et al. Proton pump inhibitor usage and the risk of myocardial infarction in the general population. Plos One 2015; 10: e0124653.
5. Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z. Risk of death among users of proton pump inhibitor: a longitudinal observational cohort study of United States veterans. BMJ Open. 2017; 7: e015735.
6. Savarino V, Dulbecco P, Savarino E. Are proton pump inhibitors really so dangerous? Digestive and Liver Disease 2016; 48: 851-859.
7. Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroen-terology 2017; 152: 706-715.
8. Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterol-ogy 2017; 153: 35-48.
9. Lazarus B, Chen Y, Wilson FP, et al. Proton pump inhibitor use and the risk of chronic kidney dis-ease. JAMA Intern Med 2016; 176: 238-246.
10. Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, et al. Proton pump inhibitors linked to hypomagnesia: a systematic review and meta-analysis of observational studies. Ren Fail 2015; 37: 1237-1241.
11. Trifan A, Stanciu C, Girleanu I, et al. Proton pump inhibitor therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. In press.
12. Tleyjeh IM, Bin Abdulhak AA, Riaz M, et al. Association between proton pump inhibitor therapy and Clostridium difficile infection: a contemporary systematic review and meta-analysis. Plos One 2012; 7: e50836.
13. Tsai CF, Chen MH, Wang YP, et al. Proton pump inhibitor increased risk for hepatic encephalopathy in patients with cirrhosis in a population study. Gastroenterology 2017; 152: 134-141.
14. Xu HB, Wang HD, Li CH, et al. Proton pump use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis. Genet Mol Res 2015; 14: 7490-7501.
15. Haenisch B, von Holt K, Wiese B, et al. Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Nerosci 2015; 265: 419-428.
16. Gomm W, von Holt K, Thome P, et al. Association of proton pump inhibitors with risk of dementia: a phamacoepidemiological claims data analysis. JAMA Neurol 2016; 73: 410-416.
17. Badiola N, Alcalde V, Pujol a, et al. The proton pump inhibitor lansoprazole enhances amyloid beta production. Plos One 2013; 8: e55837.
18. Wang YF, Chen YT, Luo JC, Chen TJ, Wu JC, Wang SJ. Proton-Pump inhibitor use and the risk of first-time ischemic stroke in the general population: a nationwide population-based study. Am J Gas-troenterol 2017; 112: 1084-1093.
19. Dunn SP, Steinhub SR, Bauer D, Charnigo RJ, Berger PB, Topol EJ. Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials. J Am Heart Assoc 2013; 2(1): p. e004564.
20. Song H, Zhu J, Lu D. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database Syst Rev 2014;12:CD010623.
21. Zelter A, Fernandez JL, Bilder C, et al. Fundic gland polyps and association with proton pump inhibi-tor intake: a prospective study in 1,780 endoscopies. Dig Dis Sci 2011; 56: 1743-1748.
Additional Files
Published
Issue
Section
License
COPYRIGHT
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
_____________________________________________________________________________________
_____________________________________________________________________________________
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
- ______________________________/_________________________
- ______________________________/_________________________
- ______________________________/_________________________
N.B. All the authors must sign this form
